Patients with persistent AF more often used beta-blockers (n (%): 20 (91%) versus paroxysmal AF: 34 (61%) p < 0.05); digoxin (n (%): 6 (27%) versus paroxysmal AF: 3 (5%), p < 0.05); ACE-inhibitors (n (%): 12 (55%) versus paroxysmal AF: 12 (21%), p < 0.05); diuretics (n (%): 15 (68%) versus paroxysmal AF: 4 (7%), p < 0.05); new oral anticoagulants (n (%): 21 (95%) versus paroxysmal AF: 30 (54%) p < 0.001 and statins (n (%): 9 (41%) versus paroxysmal AF: 10 (10%), p < 0.05). Here, ACE is linked to Paroxysmal atrial fibrillation.